Outcomes in Breast Cancer Patients Who Refuse Recommended Therapy
This video reviews outcomes among breast cancer patients in the United States who refused recommended therapy for their cancer.
In this video, Skyler Johnson, MD, of the Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, discusses an observational study that looked at outcomes among breast cancer patients in the United States who, at some point during their course of treatment, refused a therapy recommended by their oncologist.
Johnson presented results of the study (abstract 2048) at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, held September 24–27 in San Diego.
Navigating AE Management for Cellular Therapy Across Hematologic Cancers
A panel of clinical pharmacists discussed strategies for mitigating toxicities across different multiple myeloma, lymphoma, and leukemia populations.
